IGC Pharma (NYSEMKT:IGC – Free Report) had its price target hoisted by Ascendiant Capital Markets from $3.50 to $3.75 in a research report report published on Tuesday morning, Benzinga reports. Ascendiant Capital Markets currently has a buy rating on the stock.
IGC Pharma Trading Down 3.1 %
Shares of NYSEMKT:IGC opened at $0.35 on Tuesday. The stock has a market cap of $26.37 million, a P/E ratio of -1.58 and a beta of 1.30. The company has a current ratio of 1.77, a quick ratio of 1.16 and a debt-to-equity ratio of 0.02.
About IGC Pharma
Read More
- Five stocks we like better than IGC Pharma
- 3 Warren Buffett Stocks to Buy Now
- 3 Small Cap Stocks That Insiders Are Buying
- Most Volatile Stocks, What Investors Need to Know
- Analysts Forecast Big Upside for Western Digital—Don’t Miss Out
- ETF Screener: Uses and Step-by-Step Guide
- 3 Must-Own Stocks for Bullish Investors in Today’s Market
Receive News & Ratings for IGC Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IGC Pharma and related companies with MarketBeat.com's FREE daily email newsletter.